A Study Characterizing Pharmacodynamic Profiles in Subjects With Chronic Obstructive Pulmonary Disease

Completed · Phase 2

Conditions studied: Chronic Obstructive Pulmonary Disease (COPD)

In brief

The purpose of this study is to characterize the pharmacodynamic profile of Formoterol Fumarate and Foradil Aerolizer

Key facts

Study ID

NCT01113593

Run by

Dey

People needed

45

Starts

2010-05-01

Last updated by the study team

2013-05-27

Who can join

Age: 40 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Able to understand the requirements of the study and provide informed consent
• A Clinical diagnosis of COPD
• A current or prior history of at least 10-pack years of cigarette smoking
• women of child-bearing potential (WOCBP) must have a negative pregnancy test at the Screening Visit and agree to avoid becoming pregnant for the duration of study

You may not qualify if…

• A Clinical Diagnosis of Asthma
• Other significant disease than COPD
• Subjects who radiation or chemotherapy within the previous 12 months
• Subjects who had any lung resection
• QTcB greater than 0.460 seconds
• History of illegal drug abuse or alcohol abuse within the past 5 years

Where it is running

• Study site — Clearwater, Florida, United States
• Study site — DeLand, Florida, United States
• Study site — Greenville, South Carolina, United States
• Study site — Spartanburg, South Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.